Steven Weber - Net Worth and Insider Trading

Steven Weber Net Worth

The estimated net worth of Steven Weber is at least $253,672 dollars as of 2024-04-29. Steven Weber is the PRINCIPAL ACCOUNTING OFFICER of IGM Biosciences Inc and owns about 26,507 shares of IGM Biosciences Inc (IGMS) stock worth over $253,672. Details can be seen in Steven Weber's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven Weber has not made any transactions after 2024-03-14 and currently still holds the listed stock(s).

Transaction Summary of Steven Weber

To

Steven Weber Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Weber owns 2 companies in total, including Spyre Therapeutics Inc (SYRE) , and IGM Biosciences Inc (IGMS) .

Click here to see the complete history of Steven Weber’s form 4 insider trades.

Insider Ownership Summary of Steven Weber

Ticker Comapny Transaction Date Type of Owner
SYRE Spyre Therapeutics Inc 2021-02-02 VP & Controller&Princ Acctg Off
IGMS IGM Biosciences Inc 2024-03-14 Principal Accounting Officer

Steven Weber Latest Holdings Summary

Steven Weber currently owns a total of 1 stock. Steven Weber owns 26,507 shares of IGM Biosciences Inc (IGMS) as of March 14, 2024, with a value of $253,672.

Latest Holdings of Steven Weber

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IGMS IGM Biosciences Inc 2024-03-14 26,507 9.57 253,672

Holding Weightings of Steven Weber


Steven Weber Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Weber has made a total of 1 transactions in IGM Biosciences Inc (IGMS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in IGM Biosciences Inc is the sale of 993 shares on March 14, 2024, which brought Steven Weber around $9,940.

Insider Trading History of Steven Weber

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Weber Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steven Weber Ownership Network

Ownership Network List of Steven Weber

No Data

Ownership Network Relation of Steven Weber


Steven Weber Owned Company Details

What does Spyre Therapeutics Inc do?

Who are the key executives at Spyre Therapeutics Inc?

Steven Weber is the VP & Controller&Princ Acctg Off of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .

Spyre Therapeutics Inc (SYRE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spyre Therapeutics Inc Insider Transactions

No Available Data

Steven Weber Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Weber. You might contact Steven Weber via mailing address: C/o Aeglea Biotherapeutics, Inc., 805 Las Cimas Parkway, Suite 100, Austin Tx 78746.

Discussions on Steven Weber

No discussions yet.